MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.cjca.2019.12.022

Медицинская библиотека · The Canadian journal of cardiology · 2019

Clinical Impact of Preprocedural Moderate or Severe Mitral Regurgitation on Outcomes After Transcatheter Aortic Valve Replacement.

Miura Mizuki, Yamaji Kyohei, Shirai Shinichi, Hayashi Masaomi, Kawaguchi Tomohiro, Arai Yoshio, Sakaguchi Genichi, Ando Kenji, Naganuma Toru, Mizutani Kazuki, Araki Motoharu, Tada Norio, Yamanaka Futoshi, Tabata Minoru, Ueno Hiroshi, Takagi Kensuke, Higashimori Akihiro, Watanabe Yusuke, Yamamoto Masanori, Hayashida Kentaro, of the OCEAN-TAVI Investigators

СтатьяМногоцентровое исследованиеПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

BACKGROUND

The influence of improved mitral regurgitation (MR) on the outcomes of transcatheter aortic valve replacement (TAVR) is unknown. Our aim was to determine the impact of significant preprocedural MR and the improvement of MR after TAVR.

METHODS

A population of 1587 patients from the Optimized Catheter Valvular Intervention Transcatheter Aortic Valve Implantation (OCEAN-TAVI) registry were evaluated. Preprocedural MR was mild or less in 1443 patients (90.9%) and moderate or severe in 144 patients (9.1%).

RESULTS

Moderate or severe MR was associated with increased risk for all-cause mortality at 1 year (adjusted hazard ratio, 1.85; 95% confidence interval [CI], 1.20-2.84; P = 0.005) and 2 years (adjusted hazard ratio, 1.64; 95% CI, 1.15-2.34; P = 0.007). At 6 months after TAVR, the MR grade improved in 77.4% of the patients with moderate or severe baseline MR. Multivariate analysis showed that the absence of previous myocardial infarction (odds ratio, 8.00; 95% CI, 1.74-36.8; P = 0.008) and beta-blocker use at baseline (odds ratio, 2.71; 95% CI, 1.09-6.70; P = 0.031) were independently associated with improved MR at 6 months (vs unchanged, worsened MR, or death). Patients with improved MR had a significantly lower rate of midterm readmission for heart failure (11.6%) than those with unchanged or worsened MR (30.8%, P = 0.007).

CONCLUSIONS

Moderate or severe MR was associated with increased risk of all-cause mortality 2 years after TAVR. Moderate or severe baseline MR was improved in most patients at 6 months after TAVR. Patients with unchanged or worsened MR had an increased rate of readmission for heart failure.

Для цитирования: Miura Mizuki, Yamaji Kyohei, Shirai Shinichi, Hayashi Masaomi, Kawaguchi Tomohiro, Arai Yoshio, Sakaguchi Genichi, Ando Kenji, Naganuma Toru, Mizutani Kazuki, Araki Motoharu, Tada Norio, Yamanaka Futoshi, Tabata Minoru, Ueno Hiroshi, Takagi Kensuke, Higashimori Akihiro, Watanabe Yusuke, Yamamoto Masanori, Hayashida Kentaro, of the OCEAN-TAVI Investigators. Clinical Impact of Preprocedural Moderate or Severe Mitral Regurgitation on Outcomes After Transcatheter Aortic Valve Replacement.. The Canadian journal of cardiology. 2019. DOI: 10.1016/j.cjca.2019.12.022.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.